Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > PMX for Covid-19 Dec 15 published Study
View:
Post by mercedesman on Dec 21, 2020 12:06pm

PMX for Covid-19 Dec 15 published Study

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21861



Key snipits - Discussion



PMX itself is used in the treatment of endotoxemia and septic shock caused bygram-negative rods. However, it is also expected to adsorb endogenous substances and cytokines

As shown in Figure 3,IL-6 levels showed an overall downward trend. 



Results

On day 14 after the first treatment, disease severity decreased in 58.3% of the patients.



Conclusion



PMX-DHP may have a beneficial effect on patients with COVID-19. Therefore, future prospective studies with acontrol group are expected to evaluate the therapeuticeffect of PMX-DHP in patients with COVID-19. 
Comment by mercedesman on Dec 27, 2020 9:52pm
I gather endedupHyonPot was lonely over the holidays and ended up taking some cheap shots.  thought I would re-post the above Study on Covid and PMX ...even tho no one offered an opinion.  Although oddly the personal attacks seemed to increase after I posted it.  Seems the good Doctor has a view point that is contrary to some slowly mounting evidence. Anyone have any ...more  
Comment by EndoHypot on Dec 27, 2020 11:29pm
Get back in your hole! You Knob Goblin.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities